hashimoto disease and glp-1 The Thyroid Twist: How Agonists Are Influencing Autoimmune Thyroid Care Thyroid Cancer and GLP-1 Medications:
Description
eNeuro (2018) 5(4):118
Finally, among GLP-1 RA, the Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O) trial demonstrated a beneficial effect of weekly efpeglenatide on MACE and on a composite kidney outcome (decrease in kidney function or severe albuminuria) [247]
It is prepared by specialized pharmacies to meet a specific prescription
PMCID: PMC10735721.
But it looks like theyre not the everything drug
